Clinical Consultation Guide : How to Optimize the Use of Prostate-specific Antigen in the Current Era
Carlsson, Sigrid LU ; Lilja, Hans LU
and Vickers, Andrew
(2015)
In European Urology Focus
1(2).
p.149-151
- Abstract
Optimizing the benefits versus harms of prostate-specific antigen screening can be achieved through stratifying screening and biopsy. This clinical consultation guide provides the scientific background and evidence-based recommendations.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/475aff1e-caad-46bc-81b2-10bf62ab1978
- author
- Carlsson, Sigrid
LU
; Lilja, Hans
LU
and Vickers, Andrew
- organization
- publishing date
- 2015-09-01
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Urology Focus
- volume
- 1
- issue
- 2
- pages
- 149 - 151
- publisher
- Elsevier
- external identifiers
-
- scopus:84960423147
- ISSN
- 2405-4569
- DOI
- 10.1016/j.euf.2015.05.001
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © 2015 European Association of Urology.
- id
- 475aff1e-caad-46bc-81b2-10bf62ab1978
- date added to LUP
- 2022-12-06 14:15:05
- date last changed
- 2025-04-04 14:05:24
@article{475aff1e-caad-46bc-81b2-10bf62ab1978,
abstract = {{<p>Optimizing the benefits versus harms of prostate-specific antigen screening can be achieved through stratifying screening and biopsy. This clinical consultation guide provides the scientific background and evidence-based recommendations.</p>}},
author = {{Carlsson, Sigrid and Lilja, Hans and Vickers, Andrew}},
issn = {{2405-4569}},
language = {{eng}},
month = {{09}},
number = {{2}},
pages = {{149--151}},
publisher = {{Elsevier}},
series = {{European Urology Focus}},
title = {{Clinical Consultation Guide : How to Optimize the Use of Prostate-specific Antigen in the Current Era}},
url = {{http://dx.doi.org/10.1016/j.euf.2015.05.001}},
doi = {{10.1016/j.euf.2015.05.001}},
volume = {{1}},
year = {{2015}},
}